Immutep

$2.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.37%) Today
+$0.10 (+3.73%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Immutep and other stocks, options, and ETFs commission-free!

About IMMP

Immutep Limited American Depositary Shares, also called Immutep, is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia. The listed name for IMMP is Immutep Limited American Depositary Shares.

CEO
Marc Voigt
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1987
Market Cap
194.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
724.54K
High Today
$2.76
Low Today
$2.61
Open Price
$2.69
Volume
555.14K
52 Week High
$7.95
52 Week Low
$0.53

IMMP Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 12, Pre-Market

You May Also Like

AZBL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure